Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
News Feed

Sigyn Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference

March 8, 2021 The Wall Street Analyzer Comments Off on Sigyn Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference

SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome (the Cytokine Storm), today […]

Spotlight

Citius Pharmaceuticals (NASDAQ: CTXR)

March 5, 2021 The Wall Street Analyzer Comments Off on Citius Pharmaceuticals (NASDAQ: CTXR)

Myron Holubiak, CEO of Citius Pharmaceuticals took time to update WSA’s listeners on the companies’ progress since their previous interview. Mr. Holubiak provided an overview of the progress on the CTXR’s main products Mino-Lok and Mino-Wrap and shared how they are adapting the product to deal with COVID compliance and restrictions. He also talked about other programs in early stage development and went over key factors that make Citius a unique investment opportunity. Have a look below: […]